cbdMD, Inc. Financial Ratios
YCBD|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-188.5%
Profit Margin
-19.0%
Net Income / Revenue
Asset Turnover
1.87
Revenue / Total Assets
Equity Multiplier
5.31
Total Assets / Equity
Composite: -188.5% (reported: -188.5%)
Profitability
Liquidity
Current Ratio
2.05
Quick Ratio
1.13
Solvency
Interest Coverage
11.96
Efficiency
Asset Turnover
1.87
Inventory Turnover
2.54
Days Sales Outstanding
15 days
As of FY2025 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-31.9%
+144.2pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.